Cargando…
Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases
BACKGROUND: Patient involvement in research increases the impact of research and the likelihood of adoption in clinical practice. A first step is to know which research themes are important for patients. We distributed a survey on research priorities to ERN-RND members, both patient representatives...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976714/ https://www.ncbi.nlm.nih.gov/pubmed/33736655 http://dx.doi.org/10.1186/s13023-020-01641-z |
_version_ | 1783667051502501888 |
---|---|
author | Post, Annemarie E. M. Klockgether, Thomas Landwehrmeyer, G. Bernhard Pandolfo, Massimo Arnesen, Astri Reinhard, Carola Graessner, Holm |
author_facet | Post, Annemarie E. M. Klockgether, Thomas Landwehrmeyer, G. Bernhard Pandolfo, Massimo Arnesen, Astri Reinhard, Carola Graessner, Holm |
author_sort | Post, Annemarie E. M. |
collection | PubMed |
description | BACKGROUND: Patient involvement in research increases the impact of research and the likelihood of adoption in clinical practice. A first step is to know which research themes are important for patients. We distributed a survey on research priorities to ERN-RND members, both patient representatives and healthcare professionals, asking them to prioritize five research themes for rare neurological diseases on a scale ranging from 1 (most important) to 5 (least important). A follow-up e-mail interview was conducted with patient representatives and professionals to assess potential reasons for differences in opinions between these two groups. RESULTS: In total, 156 responses were analysed: 61 from professionals and 95 from patient representatives. They covered all ERN-RND disease groups and came from 20 different EU countries. Almost half of the respondents considered ‘Developing therapies and preventive strategies’ the most important research theme. In particular, patient representatives prioritized this theme more often than professionals, while professionals prioritized ‘Disease mechanisms and models’. Patient representatives indicated that therapies and prevention were of the utmost importance to them, because their lives are often heavily impacted by the disease and their main goal is to relief the burden of disease. Professionals indicated that investigating disease mechanisms will lead to more knowledge and is indispensable for finding new treatments. CONCLUSIONS: Patients and professionals have different opinions on which research theme should have priority. A qualitative follow-up shows that they respect each others’ view points. Different stakeholders involved in research should be aware of their differences in research theme priority. Explaining these differences to each other leads to more understanding, and could improve patient engagement in research. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-7976714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79767142021-03-19 Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases Post, Annemarie E. M. Klockgether, Thomas Landwehrmeyer, G. Bernhard Pandolfo, Massimo Arnesen, Astri Reinhard, Carola Graessner, Holm Orphanet J Rare Dis Research BACKGROUND: Patient involvement in research increases the impact of research and the likelihood of adoption in clinical practice. A first step is to know which research themes are important for patients. We distributed a survey on research priorities to ERN-RND members, both patient representatives and healthcare professionals, asking them to prioritize five research themes for rare neurological diseases on a scale ranging from 1 (most important) to 5 (least important). A follow-up e-mail interview was conducted with patient representatives and professionals to assess potential reasons for differences in opinions between these two groups. RESULTS: In total, 156 responses were analysed: 61 from professionals and 95 from patient representatives. They covered all ERN-RND disease groups and came from 20 different EU countries. Almost half of the respondents considered ‘Developing therapies and preventive strategies’ the most important research theme. In particular, patient representatives prioritized this theme more often than professionals, while professionals prioritized ‘Disease mechanisms and models’. Patient representatives indicated that therapies and prevention were of the utmost importance to them, because their lives are often heavily impacted by the disease and their main goal is to relief the burden of disease. Professionals indicated that investigating disease mechanisms will lead to more knowledge and is indispensable for finding new treatments. CONCLUSIONS: Patients and professionals have different opinions on which research theme should have priority. A qualitative follow-up shows that they respect each others’ view points. Different stakeholders involved in research should be aware of their differences in research theme priority. Explaining these differences to each other leads to more understanding, and could improve patient engagement in research. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-03-18 /pmc/articles/PMC7976714/ /pubmed/33736655 http://dx.doi.org/10.1186/s13023-020-01641-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Post, Annemarie E. M. Klockgether, Thomas Landwehrmeyer, G. Bernhard Pandolfo, Massimo Arnesen, Astri Reinhard, Carola Graessner, Holm Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases |
title | Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases |
title_full | Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases |
title_fullStr | Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases |
title_full_unstemmed | Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases |
title_short | Research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the European Reference Network for Rare Neurological Diseases |
title_sort | research priorities for rare neurological diseases: a representative view of patient representatives and healthcare professionals from the european reference network for rare neurological diseases |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976714/ https://www.ncbi.nlm.nih.gov/pubmed/33736655 http://dx.doi.org/10.1186/s13023-020-01641-z |
work_keys_str_mv | AT postannemarieem researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases AT klockgetherthomas researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases AT landwehrmeyergbernhard researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases AT pandolfomassimo researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases AT arnesenastri researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases AT reinhardcarola researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases AT graessnerholm researchprioritiesforrareneurologicaldiseasesarepresentativeviewofpatientrepresentativesandhealthcareprofessionalsfromtheeuropeanreferencenetworkforrareneurologicaldiseases |